Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 22Breast Neoplasms 6Sleep Wake Disorders 1Sarcoma, Ewing 1Sarcoma 1Prostate Adenocarcinoma 1Polycystic Ovary Syndrome 1Osteosarcoma 1Lymphoma 1Infertility 1Hematopoietic and Lymphatic System Neoplasm 1Fatigue 1

Interventions

Metformin 21Letrozole 11Clomiphene 7dapagliflozin 4Contraceptives, Oral 4Chorionic Gonadotropin 4cetrorelix 3Liraglutide 3Inositol 3follitropin beta 2follitropin alfa 2drospirenone and ethinyl estradiol combination 2Musculoskeletal Manipulations 2Glycoprotein Hormones, alpha Subunit 2DLBS3233 2Cholecalciferol 2semaglutide 1saxagliptin 1lime 1follicle stimulating hormone, human, with HCG C-terminal peptide 1drospirenone 1cinnulin PF 1Urofollitropin 1Triptorelin Pamoate 1Treatment Expectations 1Thioctic Acid 1Tamoxifen 1Tablets 1Sugars 1Sperm Injections, Intracytoplasmic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Polycystic Ovary Syndrome × Triptorelin Pamoate × Clear all
NCT01402336 2017-10-10

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

Seoul National University Hospital

Phase 3 Completed
43 enrolled

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡